Clinical trials
Phase 1 Granulomatous Disease, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| Bellicum Pharmaceuticals | 1 |
| Emory University | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Granulomatous Disease, Chronic | 14 |
| Anemia, Diamond-Blackfan | 2 |
| Anemia, Sickle Cell | 2 |
| Dyskeratosis Congenita | 2 |
| Fanconi Anemia | 2 |
| Graft vs Host Disease | 2 |
| Lymphohistiocytosis, Hemophagocytic | 2 |
| Primary Immunodeficiency Diseases | 2 |
| Shwachman-Diamond Syndrome | 2 |
| Anemia, Aplastic | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.